RISK OF CATARACT SURGERY IN SUBJECTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA IN PROLONGED TREATMENT WITH STATINS

被引：0
|
作者：
Marco Benedi, V. [1 ]
Laclaustra, M. [1 ]
Casado-Dominguez, J. M. [1 ]
Villa Pobo, R. [1 ]
Mateo-Gallego, R. [1 ]
Sanchez-Hernandez, C. R. M. [1 ]
Blanco Nuez, M. [1 ]
Ortega-Martinez De Victoria, E. [1 ]
Sitges, M. [1 ]
Pedro-Botet, J. [1 ]
Puzo, J. [1 ]
Villarroel, T. [1 ]
Civeira, F. [1 ]
机构：
[1] Unidad Lipidos & Arterioesclerosis, Med Interna, Zaragoza, Spain
来源：
ATHEROSCLEROSIS | 2020年 / 315卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
615
引用
收藏
页码：E81 / E81
页数：1
相关论文
共 50 条
  • [1] Cataract Surgery in Elderly Subjects with Heterozygous Familial Hypercholesterolemia in Prolonged Treatment with Statins
    Marco-Benedi, Victoria
    Laclaustra, Martin
    Sanchez-Hernandez, Rosa M.
    Ortega-Martinez De Victoria, Emilio
    Pedro-Botet, Juan
    Puzo, Jose
    Civeira, Fernando
    [J]. JOURNAL OF CLINICAL MEDICINE, 2021, 10 (16)
  • [2] AORTIC STENOSIS IN SUBJECTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA IN PROLONGED TREATMENT WITH STATINS.
    Marco-Benedi, V.
    Casado-Dominguez, J. M.
    Villa Pobo, R.
    Mateo-Gallego, R.
    Perez Calahorra, S.
    Sanchez-Hernandez, R.
    Blanco Nuez, M.
    Ortega-Martinez de Victoria, E.
    Amor Fernandez, A. J.
    Zambon, D.
    Sitges Carreno, M.
    Pedro-Botet, J.
    Puzo, J.
    Villarroel, T.
    Civeira, F.
    [J]. ATHEROSCLEROSIS, 2019, 287 : E182 - E182
  • [3] Optimal Treatment using Statins from Childhood in Heterozygous Familial Hypercholesterolemia
    Nohara, Atsushi
    [J]. JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2016, 23 (01) : 39 - 43
  • [4] CARDIOVASCULAR DISEASE IN HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA SUBJECTS ON STATIN TREATMENT
    Marco-Benedi, V.
    Perez-Calahorra, S.
    Plana, N.
    Pedro-Botet, J. C.
    Ascaso, J.
    Lahoz, C.
    Almagro, F.
    Ros, E.
    Brea, A.
    Suarez-Tembra, M.
    Sanchez-Hernandez, R. M.
    Vila Belmonte, A.
    Civeira, F.
    [J]. ATHEROSCLEROSIS, 2016, 252 : E44 - E44
  • [5] Using Statins to Treat Heterozygous Familial Hypercholesterolemia in Children
    Joiner, Pete
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2010, 30 (11) : E243 - E243
  • [6] IMPACT OF STATINS ON THE CLINICAL FATE OF HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
    Harada-Shiba, M.
    Sugisawa, T.
    Yoshimasa, Y.
    Yamamoto, A.
    Yokoyama, S.
    Tomoike, H.
    [J]. ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (02)
  • [7] LIPID LOWERING THERAPY WITH STATINS IN PATIENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
    Korneva, V. A.
    Kuznetsova, T. Yu
    Tihova, G. P.
    [J]. KARDIOLOGIYA, 2019, 59 (03) : 27 - 35
  • [8] Diagnosis and Treatment of Heterozygous Familial Hypercholesterolemia
    McGowan, Mary P.
    Hosseini Dehkordi, Seyed Hamed
    Moriarty, Patrick M.
    Duell, P. Barton
    [J]. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2019, 8 (24):
  • [9] Treatment of children with heterozygous familial hypercholesterolemia
    Reiner, Zeljko
    Sahebkar, Amirhossein
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2020, 304 : 177 - 178
  • [10] Inclisiran for the Treatment of Heterozygous Familial Hypercholesterolemia
    Raal, Frederick J.
    Kallend, David
    Ray, Kausik K.
    Turner, Traci
    Koenig, Wolfgang
    Wright, R. Scott
    Wijngaard, Peter L. J.
    Curcio, Danielle
    Jaros, Mark J.
    Leiter, Lawrence A.
    Kastelein, John J. P.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (16): : 1520 - 1530
12345